首页 › 基金 › ABG Innovation Capital Partners III GP Ltd › WHWK
ABG Innovation Capital Partners III GP Ltd 对 WHWK 的持仓历史
WHITEHAWK THERAPEUTICS INC · 医疗保健
ABG Innovation Capital Partners III GP Ltd 在 Q4 2025 的 13F 申报中披露持有 WHWK(WHITEHAWK THERAPEUTICS INC)26,666 股,市值约 US$65K,约占其申报组合的 100.00%,在其申报持仓中市值排名第 1 位。 ABG Innovation Capital Partners III GP Ltd 最近 10 个申报季度中有 10 个季度披露了 WHWK 持仓,最早可追溯至 Q3 2023。
最后更新: 2026-10-18 · 来源: SEC EDGAR Form 13F-HR
ABG Innovation Capital Partners III GP Ltd 对 WHWK 的持仓演变
ABG Innovation Capital Partners III GP Ltd 于 Q3 2023 首次披露 WHWK 持仓:26,666 股(约 US$129K)。 在 10 次申报中,ABG Innovation Capital Partners III GP Ltd 的持股数量始终未变。 最近一期申报(Q4 2025)显示持股 26,666 股、市值约 US$65K。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q3 2023 | 26.67K | $129.06K | 新进 |
| Q4 2023 | 26.67K | $53.87K | 持有 |
| Q1 2024 | 26.67K | $62.40K | 持有 |
| Q2 2024 | 26.67K | $38.93K | 持有 |
| Q3 2024 | 26.67K | $54.93K | 持有 |
| Q4 2024 | 26.67K | $84.13K | 持有 |
| Q1 2025 | 26.67K | $47.47K | 持有 |
| Q2 2025 | 26.67K | $49.87K | 持有 |
| Q3 2025 | 26.67K | $50.66K | 持有 |
| Q4 2025 | 26.67K | $64.53K | 持有 |
折线上的点按变动类型着色;缺失季度表示该季未申报持仓。
关于 WHWK 与 13F 数据
WHWK(WHITEHAWK THERAPEUTICS INC)属于医疗保健行业。我们追踪的基金中还有 49 只申报持有 WHWK,申报仓位最大的包括:Yu Fan (US$22.3M), ACUTA CAPITAL PARTNERS, LLC (US$21.5M), QVT Financial LP (US$21.1M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
其它持有 WHWK 的基金
- Yu Fan 4.86M 股 · $22.26M · Q2 2026
- ACUTA CAPITAL PARTNERS, LLC 4.69M 股 · $21.46M · Q2 2026
- QVT Financial LP 4.62M 股 · $21.14M · Q2 2026
- MONTANOVA CAPITAL, LLC 4.30M 股 · $19.69M · Q2 2026
- Avoro Capital Advisors LLC 2.85M 股 · $13.05M · Q2 2026
- KVP Capital Advisors, LP 2.17M 股 · $9.92M · Q2 2026
- ACORN CAPITAL ADVISORS, LLC 1.14M 股 · $5.22M · Q2 2026
- STEMPOINT CAPITAL LP 1.02M 股 · $4.68M · Q2 2026
- Ally Bridge Group (NY) LLC 817.94K 股 · $3.75M · Q2 2026
- Verdad Advisers, LP 301.48K 股 · $1.38M · Q2 2026
更多关于 ABG Innovation Capital Partners III GP Ltd
常见问题
How long has ABG Innovation Capital Partners III GP Ltd held WHWK?
ABG Innovation Capital Partners III GP Ltd has disclosed WHWK holdings in 10 of the last 10 reported quarters, going back to Q3 2023.
What is ABG Innovation Capital Partners III GP Ltd's current position in WHWK?
As of Q4 2025, ABG Innovation Capital Partners III GP Ltd holds 26.67K shares of WHWK (WHITEHAWK THERAPEUTICS INC), valued at $64.53K, representing 100.00% of its reported portfolio and ranking #1.
Has ABG Innovation Capital Partners III GP Ltd been buying or selling WHWK?
In the latest 13F filing (Q4 2025), ABG Innovation Capital Partners III GP Ltd held unchanged its position in WHWK.
Which other funds hold WHWK?
Other major institutional holders of WHWK include Yu Fan, ACUTA CAPITAL PARTNERS, LLC, QVT Financial LP, among 49 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.